New Concepts in MRI Contrast Safety and Management
Wednesday, October 4, 2023 at 2:00 PM - 3:00 PM EDT
Identify the different Gadolinium-based contrast agent classifications.
Explain how Gadolinium-based contrast agent stability and safety is evaluated.
Describe the concept of gadolinium-based contrast agent "relaxivity".
Ari D. Goldberg, MD, PhD, Medical Director, Body Imaging, Medical Director, MRI, Loyola University Medical Center
Sponsored by: Guerbet
MRI contrast agents continue to be developed, with a focus on continued improvements in stability and safety, as well as maximization of image clarity. These distinctions rest in the molecular structure of the particular gadolinium-based contrast agent. Understanding the relative safety and efficacy of these agents is important in the radiologic management of patients. During this webinar, we’ll look closely at novel advances related to MRI contrast safety and management; understanding the risks associated with various agents as well as their efficacy.
In this webinar, attendees will learn how to:
Thank you to our webinar sponsor Guerbet. Thanks to their sponsorship, webinar registration is complimentary and you do not have to be an AHRA member to attend.
Register Online Now!
CE credit is pending approval for this webinar. You will receive login instructions the day before the webinar via email. Please test your connection prior to the webinar.